On June 1, 2022 SQZ Biotechnologies (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, reported that Armon Sharei, Ph.D., Chief Executive Officer and Founder of SQZ Biotechnologies, will present at the Jefferies Healthcare Conference on June 8, in New York, NY (Press release, SQZ Biotech, JUN 1, 2022, View Source [SID1234615368]). Presentation time and webcast information is available below.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
PRESENTATION DETAILS
Wednesday, June 8
Jefferies Healthcare Conference
2:30-2:55 p.m. ET
Webcast
Conference webcast details and the company’s most recent corporate overview presentation will be available on the Investors section of the SQZ website. Replay will be available for 90 days.
Based on guidance from the SEC, investors should note that the company may announce future healthcare conference presentations on the Events & Presentations page of the Investor Relations section of its corporate website, investors.sqzbiotech.com. It is possible that the information posted there could be deemed to be material information.